Rapid Response® COVID-19 Antigen Rapid Test: Nasal Swab

The Rapid Response® COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset.
This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection.
Positive results:
- Indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
- Do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Negative results:
- Should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management.
Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. The Rapid Response® COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
Pursuant to section 5 of the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19, made by the Minister of Health on March 18, 2020, the Rapid Response™ COVID-19 Antigen Rapid Test Device is now authorized for sale or importation in Canada.
To learn more about the product, visit our website: www.btnx.com
For information on purchase orders please contact your local sales representative or contact us at [e-mail] or 1-888-339-9964.